Skip to main content

25th September 2017

UoM study paves way for treating form of dwarfism

Re-purposed drug yields hopeful results
Categories: ,

A study carried out in mice at the University of Manchester — in collaboration with Murdoch Children’s Research Institute, Australia, and the Institute of Genetic Medicine, Newcastle University — has led researchers to believe the drug carbamazepine, used commonly to treat epilepsy and bi-polar disorder, could also be useful in promoting bone growth for people with metaphyseal chondrodysplasia type Schmid (MCDS) (commonly referred to as ‘dwarfism’).

This disorder causes skeletal dysplasia, which impedes bone growth and leads to disproportionately short limbs. Administering mice with carbamazepine was shown to mitigate the effects of the MCDS, leading to a potential treatment for people with dwarfism.

Human trials are said to be taking place at the end of the year.

University of Manchester biochemist Professor Ray Boot-Handford who led the study, said: “The indication from this study is that carbamazepine might work in a number of other conditions, where the same process involving mutant protein accumulation takes place.

“But clearly, the next stage is to test it in humans.”

Another researcher, Professor Michael Briggs, from Newcastle University said: “It exemplifies the power of drug re-purposing for rare diseases: there has been no involvement of big pharma and this inexpensive drug has had a great safety record since the 1950s.”

MCDS is caused by a mutation in ‘collagen X’, a protein responsible for cell differentiation and bone growth. It is believed that the introduction of carbamazepine degrades the mutant form of collagen X, allowing the cells to differentiate and grow properly.

In the mice studied, three weeks of drug administration showed a marked reduction of hip dysplasia and misallignment. The results are published in The Journal of Clinical Investigation.

This is not the first time that drugs used for one disorder have been found to treat or cure other, seemingly unrelated disorders; Sildenafil (or ‘Viagra’) was originally developed as a drug to treat pulmonary hypertension, but was also accidentally found to treat erectile dysfunction.

More Coverage

Record 159 students apply to LeadMCR

159 students have applied, breaking the record set in 2016

Killing consumerism: Are we headed to disposal doom?

In his keynote presentation, Professor Mark Miodownik deliberates on the perils of consumerism, how we might manage to bring it to a sustainable future, and its obsolescence

John Rylands Library to undergo major £7.6m transformation

The John Rylands will undergo a £7.6m revision, allowing the building to meet mid-21st century needs

University round-up: new 24/7 helpline, (nearly) oldest-ever graduate, and a rise in burglaries

Read the latest news from UK universities, featuring a new 95-year-old graduate and the rollout of a new 24/7 helpline service